Correlation Between Cardio Diagnostics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and ZyVersa Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and ZyVersa Therapeutics.
Diversification Opportunities for Cardio Diagnostics and ZyVersa Therapeutics
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cardio and ZyVersa is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and ZyVersa Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 0.84 times more return on investment than ZyVersa Therapeutics. However, Cardio Diagnostics Holdings is 1.19 times less risky than ZyVersa Therapeutics. It trades about -0.01 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 31.00 in Cardio Diagnostics Holdings on August 28, 2024 and sell it today you would lose (4.00) from holding Cardio Diagnostics Holdings or give up 12.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| ZyVersa Therapeutics |
Cardio Diagnostics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and ZyVersa Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |